Women living with HIV face a substantially higher risk of persistent HPV infection and cervical disease, yet HIV care and cervical-cancer prevention have often developed as separate service pathways. That separation creates a paradox: a health system may successfully retain women in HIV care while still failing to complete the screening, triage and treatment steps needed to prevent cervical cancer.
Implementation programmes in Kenya are testing what integration means in practice by bringing HPV-based screening, navigation and follow-up into HIV-care settings. The important distinction is that integration is more than co-location. Offering a second service in the same clinic does not guarantee that results are communicated, abnormal findings are acted upon, data systems connect, or treatment is completed.
The wider cervical-cancer implementation literature makes the same point. Disease-specific programmes can become useful platforms for related health needs when workflows, people, information and accountability are deliberately connected. But integration also creates risks: added workload, longer visits, competing priorities and the possibility that one service weakens another. The scientific question is therefore not simply whether services can be combined, but whether the combined pathway preserves quality and equity for both.